Vitrakvi Capsules 25mg, manufactured by Bayer Pharmaceutical, contains Larotrectinib sulfate (YJ code: 4291071M1029, standard: 25mg 1 capsule). It is a selective tropomyosin receptor kinase (TRK) inhibitor used to treat solid tumors that harbor neurotrophic receptor tyrosine kinase (NTRK) gene fusions, which drive cancer growth by promoting uncontrolled cell proliferation and survival.
Vitrakvi Capsules 25mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
